Prosecution Insights
Last updated: April 19, 2026

TriSalus Life Sciences, Inc.

7 pending office actions

Portfolio Summary

7
Total Pending OAs
0
Final Rejections
7
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18285063 CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS HUDSON, AMY ROSE 1636 Non-Final OA Sep 29, 2023
18027895 CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS WHITEMAN, BRIAN A 1636 Non-Final OA Mar 22, 2023
18027883 CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS POLIAKOVA-GEORGAN, EKATERINA 1637 Non-Final OA Mar 22, 2023
18087508 SYSTEMS AND METHODS FOR SELECTIVELY INDUCING VASOCONSTRICTION TO INCREASE THERAPEUTIC UPTAKE IN TISSUE JIAN, SHIRLEY XUEYING 3792 Non-Final OA Dec 22, 2022
18087767 SYSTEMS AND METHODS FOR CONTROLLING FLOW OF THERAPEUTIC AGENT DELIVERED TO AN INFUSION CATHETER PATEL, SHEFALI DILIP 3783 Non-Final OA Dec 22, 2022
17951874 TISSUE HOMOGENIZATION BUFFER FOR EFFICIENT QUANTITATION OF A THERAPEUTIC OLIGONUCLEOTIDE IN MULTIPLE TISSUES POHNERT, STEVEN C 1683 Non-Final OA Sep 23, 2022
17236446 Atraumatic Occlusive System with Compartment for Measurement of Vascular Pressure Change MEDWAY, SCOTT J 3783 Non-Final OA Apr 21, 2021

Managing TriSalus Life Sciences, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month